Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Restructuring Costs (2024)

Whitehawk Therapeutics (WHWK) has disclosed Restructuring Costs for 1 consecutive years, with $2.6 million as the latest value for Q3 2024.

  • Quarterly Restructuring Costs changed N/A to $2.6 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $2.6 million for FY2024, N/A changed from the prior year.
  • Restructuring Costs for Q3 2024 was $2.6 million at Whitehawk Therapeutics.
  • The five-year high for Restructuring Costs was $2.6 million in Q3 2024, with the low at $2.6 million in Q3 2024.